Valeant (VRX) 3Q Earnings Preview: Underlying RX Trends Remain Weak - Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Stocks and yen struggle as tech troubles weigh
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steady as US demand concerns balance Middle East conflict risks
- Yen at multi-decade lows, dollar drops before US data
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
U.S. election, rate uncertainty rattle Wall Street
November 1, 2016 7:26 AM EDTBy Lewis Krauskopf
(Reuters) - Wall Street sold off on Tuesday, with the S&P 500 closing at the lowest level since July 7, amid growing concern over the impending U.S. presidential election and prospects for higher U.S. interest rates.
Stocks pared losses after falling steeply in early afternoon trading as the S&P 500 breached a key technical level.
The tumultuous presidential race between Democrat Hillary Clinton and Republican Donald Trump has appeared to tighten in the past week after news that the FBI was investigating more emails as part of a probe into... More
Valeant Pharma (VRX): Was Cautious, Investigation Doesn't Help - Mizuho
November 1, 2016 6:10 AM EDTMizuho Securities analyst, Irina Koffler, reiterated her Neutral rating on shares of Valeant Pharmaceuticals (NYSE: VRX) after the stock sold off on news of an ongoing (not new) criminal investigation.
The analyst was cautious heading into the 3Q:16 earnings... More
Valeant Pharma (VRX) Issues Comments on Anonymous Press Reports
October 31, 2016 4:47 PM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) today issued the following statement regarding comments attributed to anonymous sources in a press report regarding the ongoing investigation being conducted by the U.S. Attorney's Office for the Southern District of New York:
"As Valeant previously stated in... More
Valeant Pharma (VRX) Comments on Press Reports; Says Fully Cooperating with Authorities
October 31, 2016 4:47 PM EDTValeant Pharma (NYSE: VRX) issued the following statement regarding comments attributed to anonymous sources in a press report regarding the ongoing investigation being conducted by the U.S. Attorney's Office for the Southern District of New York:
"As Valeant previously stated in... More
